|
EP3402804A1
|
|
Formulations and methods for treating ulcerative colitis
|
|
CA3001727A1
|
|
Compositions and method for the treatment and detection of colon cancer
|
|
US2016367623A1
|
|
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US2016367622A1
|
|
Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
|
|
US2015273013A1
|
|
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
CN106061494A
|
|
Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
|
|
KR20160039577A
|
|
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
|
EP2970384A1
|
|
Agonists of guanylate cyclase and their uses
|
|
EP2958577A2
|
|
Guanylate cyclase receptor agonists for use in colonic cleansing
|
|
US2014187470A1
|
|
Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
|
|
CA3100941A1
|
|
Process of preparing guanylate cyclase c agonists
|
|
CA2813993A1
|
|
Method of preparation of antiviral compounds and useful intermediates thereof
|
|
AU2011302006A1
|
|
Formulations of guanylate cyclase C agonists and methods of use
|
|
CA2745694A1
|
|
Formulations of guanylate cyclase c agonists and methods of use
|
|
US2010093635A1
|
|
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
CA2930674A1
|
|
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
AU2009256156A1
|
|
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
CN103638514A
|
|
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
|
